This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions | MicrobiomeTrials
← Back to trials NCT07734064
A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-08-14Est. Completion: 2029-09-30
Enrollment target: 30 participantsLocations Associated Retina Consultants, Phoenix, Arizona, United States Deep Blue Retina, Southaven, Mississippi, United States Cincinnati Eye Institute, Cincinnati, Ohio, United States Retina Foundation of Southwest, Dallas, Texas, United States Other microbiome trials you might be interested in Low Vision Retinitis Pigmentosa Stargardt Disease 1 Stargardt Disease 3 Stargardt Disease 4 Albinism
Purpose:
To validate a newly developed battery of performance-based tests of visual function to be presented using virt…
Belfast, United Kingdom Completed Dec 31, 2021
Retinal Degeneration ABCA4-Related Retinopathies
Background:
\- The ABCA4 gene contains a blueprint for the ABCA4 protein. When this protein is absent or faulty (such a…
Bethesda, United States